Neurocrine Biosciences, Inc. announced the appointment of Lewis Choi as Chief Information Officer, effective June 9, 2025. Choi, an accomplished leader with 25 years of experience in information technology and artificial intelligence, will be responsible for driving the vision and long-term strategic direction of the company's technology initiatives.
Choi joins Neurocrine after a 13-year career at Thermo Fisher Scientific, where he most recently served as Vice President of AI Automation & Data. His previous roles included Global Vice President of Digital Platforms, Engineering & Generative AI, and Vice President of Digital Solutions for APAC and Emerging Markets.
His appointment comes at a pivotal time for Neurocrine, as the company launches CRENESSITY, grows INGREZZA, and advances its pipeline. Advancements in technology are expected to play a critical role in advancing the company's mission to help more patients.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.